View Full Paper

Owner Consent Verified
Policy Brief 4.8

Natural Language Processing Adoption in Pharmaceutical Firms: Cost–Benefit Analysis — Evidence from East Africa

11
Pages
Harvard
Style
~ 11–18 mins
Reading Time
UX Impact Green Finance
Abstract

This policy brief investigates “Natural Language Processing Adoption in Pharmaceutical Firms: Cost–Benefit Analysis — Evidence from East Africa” using a difference-in-differences analysis. Through a socio-technical lens, the analysis integrates multi-source data to derive a stakeholder-aligned blueprint for researchers and practitioners.

Download PDF Order Similar Paper Save

Natural Language Processing Adoption in Pharmaceutical Firms: Cost–Benefit Analysis — Evidence from East Africa

ABSTRACT
Natural Language Processing Adoption in Pharmaceutical Firms: Cost–Benefit Analysis — Evidence from East Africa is unpacked across themes: risks, benefits, interoperability, and ethics. Limitations and future research paths are noted.
1
Open full preview
Related Papers
Browse all
25 Pages 4.7
Equity And Access in EdTech for Pharmaceutical Firms: 2021–2029 Trends
Green Finance MLOps Esports
View Paper
16 Pages 4.7
Gaming & Esports and Cost–Benefit Analysis among Gig Workers — Post-Pandemic Lessons
HCI Esports Tourism
View Paper
14 Pages 4.5
Innovation Diffusion in Human-Computer Interaction for Remote Software Engineers: 2021–2027 Trends
DevSecOps InsurTech AIOps
View Paper